Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,838 | 174,935 | 102,055 | 52,205 | 71,734 |
| Receivables | 265,737 | 251,799 | 148,186 | 132,241 | 110,414 |
| Inventories | 280,347 | 296,332 | 217,263 | 211,429 | 189,133 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 30,564 |
| Other current assets | 0 | 0 | 0 | 0 | 99,785 |
| TOTAL | $775,082 | $822,146 | $495,170 | $438,495 | $529,321 |
| Non-Current Assets | |||||
| PPE Net | 300,112 | 269,251 | 222,369 | 205,181 | 193,626 |
| Intangibles | 2,005,971 | 2,097,532 | 1,071,746 | 1,116,129 | 776,047 |
| Other Non-Current Assets | 26,722 | 22,328 | 18,669 | 14,419 | 88,425 |
| TOTAL | $2,332,805 | $2,389,111 | $1,312,784 | $1,335,729 | $1,058,098 |
| Total Assets | $3,107,887 | $3,211,257 | $1,807,954 | $1,774,224 | $1,587,419 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 76,050 | 93,967 | 29,057 | 34,772 | 28,867 |
| Accrued Expenses | 160,238 | 161,100 | 87,732 | 84,314 | 74,452 |
| Other current liabilities | 3,764 | 22,793 | N/A | N/A | N/A |
| TOTAL | $262,552 | $348,911 | $123,601 | $139,127 | $126,025 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,210,513 | 1,781,142 | 665,000 | 481,875 | 413,125 |
| Deferred Revenues | N/A | 11,051 | 6,812 | 5,666 | 5,176 |
| Other Non-Current Liabilities | 201,248 | 53,768 | 30,745 | 246,888 | 243,530 |
| TOTAL | $1,469,539 | $1,900,040 | $844,686 | $883,654 | $757,072 |
| Total Liabilities | $1,732,091 | $2,248,951 | $968,287 | $1,022,781 | $883,097 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,229 | 78,494 | 74,816 | 74,001 | 65,557 |
| Common Shares | 880 | 813 | 777 | 917 | 416 |
| Retained earnings | 348,373 | 285,186 | 220,443 | 145,879 | 314,960 |
| Other shareholders' equity | -45,058 | -23,451 | -57,205 | -48,023 | -23,609 |
| TOTAL | $1,375,796 | $962,306 | $839,667 | $751,443 | $704,322 |
| Total Liabilities And Equity | $3,107,887 | $3,211,257 | $1,807,954 | $1,774,224 | $1,587,419 |